AACR IO 2026 Keynote Highlights: Cancer Vaccines Are Here, and Upgrading T Cells To Thrive in the Tumor Microenvironment
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
An AACR Special Conference on early-onset cancers explored possible explanations for the alarming increase in cancer among younger adults.
Recently updated federal guidelines for cervical cancer screening and the HPV vaccine could make these prevention strategies more convenient.
Keith Flaherty, William Hait, Nina Bhardwaj, Dana Pe’er, and Marcia Cruz-Correa forecast what advances to expect in cancer research...
In the last quarter of 2025, the FDA announced 20 approvals in oncology, including treatments for lung cancer, multiple...
The countdown to the new year is nearly upon us, but no need to count down to the last...
At the SABCS 2025 View From the Trenches session, experts discussed how new clinical trial results might transform breast...
A year-end review of some of the new cancer treatments, exciting breakthroughs, and insights into cancer's development that emerged...
At SABCS 2025, studies show some patients with early-stage breast cancer can skip steps like SLNB or MRI without...
In clinical trials presented at SABCS, a mobile health tool and acupuncture helped to improve breast cancer survivors' quality...
Amid the debate over menopausal hormone therapy and cancer risk, researchers at SABCS provided some clarity for women with...